Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Pancrelipase lipase is a lipase used to treat pancreatic exocrine insufficiency. Pancrelipase, in general, is composed of a mixture of pancreatic enzymes which include amylases, lipases, and proteases.
- Mechanism
- Curator reviewed · 1 reference
Pancrelipase lipase catalyzes the hydrolysis of triglycerides to monoglycerides, glycerol, and fatty acids. This activity is performed by the hydrolyzation of the esters of fatty acids. The hydrolysis is started by the action of colipase which helps to anchor lipase to the lipid-water membrane of the micelle producing a surface change on lipase. The hydrophobic active site is exposed for the binding of triglycerides and further interaction with the catalytic triad. In this triad, the function of the three amino acids allows the formation of a deprotonated serine which becomes a nucleophile and act on the ester carbonyl of the fatty acids for the later formation of monoglyceride and fatty acid monomers.
- Primary indication
- Please refer to DB00085.Curator reviewed · 13 structured indications
- Formula / weight
- 48000.0 Da
- First approval
- Canada, 2011 · United States, 2009
- Also known as
- Lipase, pancreatic · Pancreatic lipase
- Brand names
- Cotazym
- Creon
- Pancrease MT
- Pancreaze
- Pertzye
- Viokace
- Zenpep
Resolves to
What you can answer from here — as of May 03, 2025
Which other approved drugs treat the same conditions as Pancrelipase lipase, and which companies have late-stage candidates in those indications?